A carregar...
The efficacy and safety of tivantinib in the treatment of solid tumors: a systematic review and meta-analysis
BACKGROUND: Tivantinib was designed to kill cancers by targeting the mesenchymal-epithelial transition (MET) protein. Although numerous tivantinib clinical trials are ongoing, tivantinib's efficacy and safety are still not clear. This meta-analysis was done to evaluate tivantinib's efficac...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5762579/ https://ncbi.nlm.nih.gov/pubmed/29348894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22615 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|